Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) and FDA 510(k) clearance for the new FARAVIEW software, which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation (PFA) System.

Oct. 11, 2024 – As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers. These challenges and more will be tackled head-on at the third annual TCT MedTech Innovation Forum on Oct. 27, at the Walter E. Washington Convention Center in Washington, D.C.

Oct. 15, 2024 — The American Medical Association recently released  a statement urging Congress to address Medicare reform during the lame duck session later this year.

Oct. 15, 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA).

The four contractors for the U.S. Centers for Medicare and Medicaid Services (CMS) – including CGS, National Government Services (NGS), Palmetto GBA and Wisconsin Physicians Service Insurance Corporation (WPS) – provided updated LCDs for current procedural terminology (CPT) codes 0623T - 0626T.

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions, a journal of The American Heart Association. Led by Dr. Pieter C.

Oct. 14, 2024 – The Institute for AI Governance in Healthcare (IAIGH) has published the draft Healthcare AI Governance Standard (HAIGS) for public comment.

The comment period opened Oct. 14, 2024, and closes Nov. 14, 2024.

The draft standard is available for review and feedback at AiHealthcareGovernance.org.

Oct. 15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend coverage for AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ image analysis software, beginning Nov. 24, 2024.

On Nov. 13, 2024, HIMSS will be presenting a webinar on "Addressing the Changing Data Demands of Next-Gen Healthcare."

The webinar will take place at 1 p.m. Central time.

The delivery of next-generation patient care relies upon seamless access to comprehensive and relevant patient data. However, the proliferation of patient data silos across multiple hosted environments can present significant integration challenges. To ensure that the full potential of next-generation healthcare solutions is realized, healthcare providers must rethink their data strategy.  

Subscribe Now